[Secondary prevention after myocardial infarct].
Trenkwalder
P
P
Medizinische Klinik, Krankenhaus des Landkreises Starnberg.
Lydtin
H
H
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000800:Angioplasty, Balloon; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004038:Diet, Reducing; D015444:Exercise; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D000074606:Smoking Prevention; D013177:Sports; D014434:Type A Personality
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002800:Cholinesterase Inhibitors; D015525:Fatty Acids, Omega-3; D000960:Hypolipidemic Agents; D001241:Aspirin